Remix Therapeutics to Present at Jefferies Healthcare Conference

CAMBRIDGE, Mass., May 25, 2023 /PRNewswire/ —¬†Remix Therapeutics (Remix), a biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced that Peter Smith, Ph.D., Co-Founder and Chief Executive Officer of Remix, will present a corporate overview at the Jefferies Healthcare Conference on Thursday, June 8, 2023, … Read more